Treace Medical Concepts, Inc.

NASDAQ:TMCI

Medical - Devices

Healthcare
$4.53 +1.87%

+$0.08 today

Market cap
$296.98M
Beta
1.41
P/E (TTM)
-4.3
EPS (TTM)
-$0.95
52W Low $1.17High $7.78

Volume 0.18M

Average 0.73M

TMCI Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Treace Medical Concepts, Inc.NASDAQ: TMCI

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt falls 92.8% from a year ago

Net debt stood at $4.01M at the end of Q1 FY2026, down 92.8% from a year earlier and up 22.4% from the prior quarter. Over 3 fiscal years it compounded at -59.5% a year.

Context

  • Net debt amounted to 2.2% of total assets at the end of Q1 FY2026, down 25.0 pp from a year earlier.
  • Net debt increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net debt keeps falling in the next quarterly balance sheet after a -92.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.01M+22.4% QoQ
Last fiscal yearDec 2025
$3.27M-94.4% YoY
Year agoMar 2025
$55.99M-92.8% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-92.8%——
1 year-94.4%——
3-year CAGR-59.5%——
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
3.27M USD
Year-over-year change
-94.4%

Net Debt vs competitors

How TMCI compares with its peers on the latest reported figures

  • TMCI's Mar 2026 net debt of $4.01M is the 5th highest of the 8 companies compared; the peer median is $74.58M.
  • Its year-over-year change of -92.8% is the 7th highest of 8, against a peer median of +57.7%.
  • Net debt amounts to 2.2% of total assets for TMCI, versus a peer median of 36.3%.
TMCI Competitors Peer median
Net Debt for TMCI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BVSBioventus Inc.Mar 2026$236.23M -26.9%-12.5%36.3%
EOLSEvolus, Inc.Mar 2026$115.11M +84.7%+70.3%52.2%
KIDSOrthoPediatrics Corp.Mar 2026$92.03M +131.5%—18.3%
TOIThe Oncology Institute, Inc.Mar 2026$74.58M +19.2%-9.4%44.3%
TMCITreace Medical Concepts, Inc.Mar 2026$4.01M -92.8%-59.5%2.2%
RXSTRxSight, Inc.Mar 2026-$6.75M +57.7%—2.2%
CBLLCeriBell, Inc.Mar 2026-$23.14M +82.4%—13.0%
LABStandard BioTools Inc.Mar 2026-$236.28M -98.0%—37.0%
Peer median (excluding TMCI) $74.58M+57.7%-9.4%36.3%

Competitors are the stored peer set for TMCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents105.83M19.47M12.98M11.35M10.71M
Short-term Investments061.78M110.22M64.33M37.66M
Net Receivables18.57M29.2M38.06M40.8M42.16M
Inventory10.56M19.33M29.25M39.26M36.03M
Other Current Assets03.62M7.85M5.67M5.5M
Total Current Assets137.97M133.4M198.36M161.4M132.05M
Property, Plant & Equipment (Net)2.85M25.48M31.56M34.4M37.37M
Goodwill0012.82M12.82M12.82M
Intangible Assets009.03M8.08M7.13M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0146K146K407K1.22M
Total Non-current Assets2.85M25.62M53.55M55.69M58.53M
Total Assets140.82M159.02M251.91M217.09M190.58M
Account Payables4.06M8.67M11.84M10.52M6.73M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities4.46M7.67M24.25M2.22M23.91M
Total Current Liabilities18.21M30.25M45.03M34.93M30.64M
Long-term Debt29.37M52.71M53.01M53.31M13.98M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities173K037K37K58.63M
Total Non-current Liabilities29.54M68.25M68.94M69.28M72.61M
Total Liabilities47.75M98.5M113.97M104.2M103.25M
Common Stock45K55K62K62K64K
Retained Earnings(41.91M)(84.72M)(134.25M)(189.99M)(248.99M)
Accumulated OCI0(27K)163K97K72K
Other Stockholders Equity00000
Minority Interest00000
Total Equity93.07M60.53M137.94M112.89M87.33M
Total Debt29.37M68.59M70.3M69.65M13.98M
Net Debt(76.47M)49.12M57.32M58.3M3.27M

Treace Medical Concepts, Inc.

NASDAQ:TMCI

Intrinsic Alpha fair value

Locked

Current Price

$4.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.